Outcome | Immunized | Non-immunized | Incremental |
---|---|---|---|
BOD-fiscal in terms of discounted lifetime gross tax loss due to premature mortality | € 117,502,550 | € 130,864,666 | -€ 13,362,116 |
BOD-societal in terms of discounted lifetime productivity loss due to premature mortality | € 209,825,982 | € 233,686,903 | -€ 23,860,921 |
Discounted lifetime HPV– related medical costs | € 692,164,462 | € 863,973,983 | -€ 171,809,521 |
Vaccination investment cost | €107,525,880 | € - | € 107,525,880 |